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Abstract Aging-induced structural and functional al-
terations of the neurovascular unit lead to impairment
of neurovascular coupling responses, dysregulation of
cerebral blood flow, and increased neuroinflammation,
all of which contribute importantly to the pathogenesis
of age-related vascular cognitive impairment (VCI).
There is increasing evidence showing that a decrease
in NAD+ availability with age plays a critical role in
age-related neurovascular and cerebromicrovascular
dysfunction. Our recent studies demonstrate that restor-
ing cellular NAD+ levels in aged mice rescues
neurovascular function, increases cerebral blood flow,
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and improves performance on cognitive tasks. To deter-
mine the effects of restoring cellular NAD+ levels on
neurovascular gene expression profiles, 24-month-old
C57BL/6 mice were treated with nicotinamide mononu-
cleotide (NMN), a key NAD+ intermediate, for 2 weeks.
Transcriptome analysis of preparations enriched for
cells of the neurovascular unit was performed by
RNA-seq. Neurovascular gene expression signatures in
NMN-treated aged mice were compared with those in
untreated young and aged control mice. We identified
590 genes differentially expressed in the aged
neurovascular unit, 204 of which are restored toward
youthful expression levels by NMN treatment. The tran-
scriptional footprint of NMN treatment indicates that
increased NAD+ levels promote SIRT1 activation in
the neurovascular unit, as demonstrated by analysis of
upstream regulators of differentially expressed genes as
well as analysis of the expression of known SIRT1-
dependent genes. Pathway analysis predicts that
neurovascular protective effects of NMN are mediated
by the induction of genes involved in mitochondrial
rejuvenation, anti-inflammatory, and anti-apoptotic
pathways. In conclusion, the recently demonstrated pro-
tective effects of NMN treatment on neurovascular func-
tion can be attributed to multifaceted sirtuin-mediated
anti-aging changes in the neurovascular transcriptome.
Our present findings taken together with the results of
recent studies using mitochondria-targeted interventions
suggest that mitochondrial rejuvenation is a critical
mechanism to restore neurovascular health and improve
cerebral blood flow in aging.
Keywords Aging . Geroscience . Vascular cognitive
impairment . Mitochondria dysfunction . Transcriptomics
Introduction
In recent years, there has been increasing appreciation
that the health of the neurovascular unit (NVU) is crit-
ical for brain health (Kisler et al. 2017; Zlokovic 2010,
2011; Iadecola 2017; Stanimirovic and Friedman 2012).
The extended NVU consists of cerebral microvessels
that receive input from neurons via astrocytic endfeet,
pericytes, and perivascular microglia (Iadecola 2017;
Stanimirovic and Friedman 2012). The NVU is respon-
sible for the tight coupling between neural activity and
regional cerebral blood flow (“neurovascular cou-
pling”), which ensures adequate oxygen and nutrient
delivery to the brain (Tarantini et al. 2017a; Toth et al.
2017). Endothelial dysfunction and/or impaired astro-
cytic function results in neurovascular uncoupling con-
tributing to cognitive impairment (Toth et al. 2017;
Tarantini et al. 2015, 2018, 2017b). In addition, cells
constituting the NVU form andmaintain the blood-brain
barrier (Zlokovic 2010, 2011; Montagne et al. 2017;
Sweeney et al. 2018, 2019a; Zlokovic 2008), regulate
transport processes and waste removal, deposit the ex-
tracellular matrix, control the structural remodeling of
the cerebral microcirculation (including angiogenesis,
vessel regression, adaptation to hypertension (Csiszar
et al. 2017; Tarantini et al. 2016, 2017c; Tucsek et al.
2014; Warrington et al. 2013; Ungvari et al. 2013,
2018a, 2017; Toth et al. 2015)), form and operate the
glymphatic system (Iliff et al. 2013; Jessen et al. 2015;
Kress et al. 2014), maintain stem-cell niches (Solano
Fonseca et al. 2016), synthesize the glycocalyx, and
control the adhesion and extravasation of inflammatory
circulating cells that participate in central nervous sys-
tem immune surveillance (Stanimirovic and Friedman
2012). With age, the phenotype and function of the cells
constituting the NVU are altered, which fundamentally
affects all of the aforementioned physiological process-
es (Kisler et al. 2017; Zlokovic 2010, 2011; Tarantini
et al. 2017a). Age-related neurovascular dysfunction is
now considered as a critical contributing factor to the
pathogenesis of both vascular cognitive impairment
(VCI) and neurodegenerative diseases, including
Alzheimer’s disease (Sweeney et al. 2019b). In order
to develop novel methods for prevention and treatment
of these diseases and to preserve cognitive function in
older adults, it is important to identify therapeutic inter-
ventions that can reverse age-related impairment of the
NVU. Understanding the role of fundamental cellular
and molecular mechanisms of aging in age-related
neurovascular impairment is critical in that regard.
Nicotinamide adenine dinucleotide (NAD+) is a co-
enzyme central to hundreds of redox reactions in eu-
karyotic cells. NAD+ also has a critical role in the
regulation of the activity of NAD+-consuming enzymes,
including SIRT1 and other sirtuins (Gomes et al. 2013;
Michan et al. 2010; Mitchell et al. 2014; Yang et al.
2007). Sirtuin enzymes are implicated in regulation of
cellular processes of aging, mitochondrial function,
stress resilience, apoptosis, and inflammation (Das
et al. 2018; Csiszar et al. 2009a, b, 2008a). Aging is
associated with cellular NAD+ depletion (Gomes et al.
2013; Massudi et al. 2012) (Yoshino, 2018 #10180),
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which has been proposed to be a critical driving force of
aging processes (Imai and Guarente 2014), impairing
nuclear and mitochondrial functions and contributing to
the genesis of many age-associated pathologies. Ac-
cordingly, restoration of cellular NAD+ biosynthesis
extends lifespan in model organisms (Anderson et al.
2002) and improves health span and extends lifespan in
murine models of aging (Zhang, 2016 #10167)
(Mitchell et al. 2018). There is emerging evidence that
vascular aging is also characterized by cellular NAD+
depletion (Tarantini et al. 2019a; Csiszar et al. 2019;
Kiss et al. 2019a). Importantly, our recent studies
showed (Tarantini et al. 2019a) that in murine models
of aging restoration of cellular NAD+ levels by chronic
treatment with the NAD+ precursor, nicotinamide
mononucleotide (NMN) (Yoshino et al. 2018) confers
potent anti-aging neurovascular effects, rescuing
cerebromicrovascular endothelial dysfunction and
neurovascular coupling responses, increasing cerebral
blood flow, and improving cognitive performance. In
cultured cerebromicrovascular endothelial cells derived
from aged rats, 5 days of treatment with NMN restored
NAD+ levels and rescued mitochondrial function and
attenuated mitochondrial oxidative stress in a sirtuin-
dependent manner (Tarantini et al. 2019a).
The present study was designed to test the hypothesis
that age-related NAD+ depletion in the NVU is causally
linked to dysregulated expression of genes important for
normal neurovascular function. A corollary hypothesis
is that functional neurovascular rejuvenation in NMN-
treated aged mice is associated with SIRT1-mediated
restoration of a youthful neurovascular mRNA expres-
sion profile. To test these hypotheses, aged mice were
treated with NMN for 2 weeks and transcriptomic sig-
natures in cells of the neurovascular unit were compared
with those in cells obtained from untreated young and
aged control mice. The transcriptomic footprint of
SIRT1 activation was analyzed, and the predicted mul-
tifaceted protective effects of NMN supplementation on
diverse aspects of cerebromicrovascular and
neurovascular biology were tested.
Methods
Animals, NMN supplementation
Young (3 months old) and aged (24 months old) male
C57BL/6 mice were purchased from the aging colony
maintained by the National Institute on Aging at Charles
River Laboratories (Wilmington, MA). The biological
age of 24-month-old mice corresponds to that of ~ 60-
year-old humans. Mice were housed under specific
pathogen-free barrier conditions in the Rodent Barrier
Facility at University of Oklahoma Health Sciences
Center under a controlled photoperiod (12 h light; 12 h
dark) with unlimited access to water and were fed a
standard AIN-93G diet (ad libitum). Mice in the aged
cohort were assigned to two groups. One group of the
aged mice was injected daily with NMN (IP injections
of 500 mg NMN/kg body weight per day) or the equiv-
alent volume of PBS for 14 consecutive days at 6 PM
and 8 AM on day 14 and were sacrificed 4 h after last
injection. Similar dosages of NMN has been shown to
exert potent anti-aging effects on mouse health span
(Csiszar et al. 2019; de Picciotto et al. 2016), including
rescue of neurovascular coupling responses, attenuation
of vascular oxidative stress, and rescue of gene expres-
sion changes in the aorta (Tarantini et al. 2019a; Kiss
et al. 2019b). All procedures were approved by the
Institutional Animal Use and Care Committees of the
University of Oklahoma Health Sciences Center. All
animal experiments complied with the ARRIVE guide-
lines and were carried out in accordance with the Na-
tional Institutes of Health guide for the care and use of
Laboratory animals (NIH Publications No. 8023, re-
vised 1978). The effects of NMN treatment on cognitive
function, neurovascular coupling responses, and micro-
vascular and aorta endothelial function in a similar
cohort of mice have been recently reported (Tarantini
et al. 2019a).
Isolation of cells of the neurovascular unit
Animals were killed and transcardially perfused with
PBS as previously described (Tarantini et al. 2019a;
Kiss et al. 2019b). The brains were quickly removed
and rinsed in ice-cold PBS, and minced into ≈ 1 mm2
pieces. The tissue was washed twice in ice-cold 1× PBS
by low-speed centrifugation (50g, 3 min). The diced
tissue was digested in a buffer solution containing col-
lagenase (800 U/g tissue), hyaluronidase (2.5 U/g tis-
sue), and elastase (3 U/g tissue) in 1 mL PBS/100 mg
tissue for 45 min at 37 °C in a rotating humid incubator.
The digested tissue was passed through a 100-μm cell
strainer. The single-cell lysate was centrifuged for 2 min
at 70g. After removing the supernatant, the pellet was
washed twice in cold PBS supplemented with 2.5% fetal
GeroScience
calf serum (FCS), and the suspension was centrifuged at
300g for 5 min at 4 °C. To create fraction enriched for
cells of the neurovascular unit, the cell suspension was
centrifuged using an OptiPrep gradient solution (Axi-
Shield, PoC, Norway). Briefly, the cell pellet was resus-
pended in Hanks’ balanced salt solution (HBSS) and
mixed with 40% iodixanol thoroughly (final concentra-
tion 17% (v/v) iodixanol solution; ρ = 1.096 g/mL).
Two milliliters of HBSS was layered on top and centri-
fuged at 400g for 15min at 20 °C. Endothelial cells with
attached astrocytes and pericytes, which banded at the
interface between HBSS and the 17% iodixanol layer,
were collected. The neurovascular-enriched fraction
was incubated for 30 min at 4 °C in the dark with anti-
CD31/PE (BD Biosciences, San Jose, CA, USA) and
anti-MCAM/FITC (BD Biosciences, San Jose, CA,
USA). After washing the cells twice with MACS buffer
(Milltenyi Biotech, Cambridge, MA, USA), anti-FITC
and anti-PE magnetic bead–labeled secondary antibod-
ies were used for 15 min at room temperature. The
endothelial/neurovascular enriched fraction was collect-
ed by magnetic separation using the MACS LD mag-
netic separation columns according to the manufac-
turer’s guidelines (Milltenyi Biotech, Cambridge, MA,
USA). Our pilot studies indicated that this method using
gentle cell dissociation protocols results in enrichment
for cerebromicorvascular endothelial cells with astro-
cytes and pericytes.
RNA isolation, cDNA synthesis, library construction,
and next generation sequencing
RNA was isolated from the samples using AllPrep
DNA/RNA Mini Kit (Qiagen) as previously described
(Imperio et al. 2016; Valcarcel-Ares et al. 2018). RNA
quantity and quality (> 8 RNA integrity number) were
measured using the RNA 6000 Nano Assay with an
Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA).
Using 1 μg RNA, cDNAwas synthesized from purified
RNA using ABI High-capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems, Foster City, CA)
(Imperio et al. 2016; Valcarcel-Ares et al. 2018). Library
construction was performed in a stranded manner to
retain the directionality of the transcripts for as de-
scribed (Valcarcel-Ares et al. 2018). In brief, prior to
RNA-seq analysis, quality control measures were im-
plemented. Concentration of RNA was ascertained via
fluorometric analysis on a Thermo Fisher Qubit Fluo-
rometer. Overall quality of RNA was verified using an
Agilent Tapestation instrument. Following initial QC
steps, sequencing libraries were generated using the
Illumina Truseq Stranded mRNA with library prep kit
according to the manufacturers protocol. Briefly, mature
mRNA was enriched for via pull down with beads
coated with oligo-dT homopolymers. The mRNA mol-
ecules were then chemically fragmented, and the first
strand of cDNA was generated using random primers.
Following RNase digestion, the second strand of cDNA
was generated replacing dTTP in the reaction mix with
dUTP. Double stranded cDNA then underwent
adenylation of 3′ ends following ligation of Illumina-
specific adapter sequences. Subsequent PCR enrich-
ment of ligated products was further selected for those
strands not incorporating dUTP, leading to strand-
specific sequencing libraries. Final libraries for each
sample were assayed on the Agilent Tapestation for
appropriate size and quantity. These libraries were then
pooled in equimolar amounts as ascertained via fluo-
rometric analyses. Final pools were absolutely quanti-
fied using qPCR on a Roche LightCycler 480 instru-
ment with Kapa Biosystems Illumina Library Quantifi-
cation reagents. Sequencing was performed on an
Illumina NovaSeq 6000 instrument with paired-end
50 bp reads.
RNA-seq data analysis and visualization
Raw sequencing reads were trimmed of their Illumina
TruSeq adapter sequences using Trimmomatic v0.35
(Bolger et al. 2014), then aligned to the mouse genome
version GRCm38 using Kallisto v0.43.03 (Bray et al.
2016). Samples were checked for outliers and separation
by principle components analysis (PCA) with the R
function prcomp. Raw expression counts were summa-
rized at the gene level to transcript-length adjusted,
library-size scaled counts per million (CPM) with the
R package tximport (Soneson et al. 2015). Differential
expression analysis was performed using the empirical
Bayes approach implemented in the R/Bioconductor
package DESeq2 (Love et al. 2014). Significantly dif-
ferentially expressed (DE) genes had an absolute log2
fold-change ≥ 0.585 (corresponding to a change of 50%
or more in expression) and the false discovery rate
(FDR)-adjusted p value ≤ 0.05. Gene annotation was
done using biomaRt (Durinck et al. 2009) in R/
Bioconductor package. Hierarchical clustering was per-
formed via the R package ComplexHeatmap.
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Functional annotation
The org.Mm.eg.db v3.8.2 R/Bioconductor package was
used to collect Gene Ontology terms associated with our
differentially expressed genes. The hypergeometric test
implemented in GOstats v2.51.0 R/Bioconductor pack-
age was used to calculate enrichment of the individual
terms (Falcon and Gentleman 2007).
We used upstream regulator analysis (URA) algo-
rithm (Kramer et al. 2014) implemented in the Ingenuity
Pathway Analysis (QIAGEN) software find upstream
regulators that potentially explains the observed gene
expression changes in our samples. The IPA uses a
manually curated database (Ingenuity Knowledge Base)
to calculate “enrichment” score (Fisher’s exact test
(FET) p value), measures the overlap of observed and
predicted regulated gene sets, and a z-score assessing
the match of observed and predicted up/downregulation
patterns.
Results
NMN treatment reverses age-related changes
in neurovascular mRNA expression profile in mice
To isolate NVU-enriched mRNA, we employed an en-
dothelial cell isolation-based strategy. Using RNA-seq
to sequence the neurovascular transcriptome, we com-
pared normalized mRNA expression values for each
sample to that in individual cell types constituting the
NVU (endothelial cells, astrocytes, and pericytes). To
achieve that goal, we developed a list of cell-specific
markers from published RNA-seq data of purified cor-
tical cell types (GEO dataset GSE52564 (Zhang et al.
2014)). Comparison of mRNA levels in the NVU sam-
ples with the input shows a significant enrichment for
endothelial cell, astrocyte, and pericyte genes (Fig. 1a).
We assessed transcriptomic changes in the NVU
associated with aging and with NMN treatment (Fig.
1b). We performed unsupervised clustering of RNA-seq
data from all samples using the topmost variably
expressed genes across all samples. This showed that
biological replicates from the same group cluster togeth-
er, and that young samples segregate away from aged
ones (Fig. 1b). PCA (Fig. 1c) of the transcriptomic data
also showed a clear separation between the young and
aged groups. Aged control mice and aged NMN-treated
mice were also segregated in the PCA and hierarchical
clustering. This finding indicated a clear difference be-
tween the transcriptome profiles of the two age groups.
In contrast, mRNA expression in young mice and
NMN-treated aged mice were similar, and these groups
did not separate well in the PCA and hierarchical
clustering.
We then determined the number of genes that are
significantly upregulated or downregulated (DE, fold-
change ≥ 1.5 or < 0.67; p < 0.05 adjusted for multiple
comparisons) in the NVU by aging or by NMN treat-
ment. We then filtered for genes that are significantly
altered (adjusted p < 0.05), expressed at an appreciable
level (fragments per kilobase of transcript per million
mapped reads > 1), and are expressed in cells of the
NVU. We identified 590 differentially expressed genes
in aged animals compared with young controls. We also
identified 459 DE genes in the NMN-treated aged mice
compared with the untreated aged controls. In Fig. 1d, a
volcano plot shows statistical significance (p value)
versus magnitude of age-related change in gene expres-
sion. Red symbols denote genes, whose expression
levels differed in the aged phenotype, but have shifted
back toward the young phenotype by NMN treatment
(discordant DE genes). The Venn diagram in Fig. 1f
shows that neurovascular expression of 204 genes,
which are differentially expressed in aged mice, was
shifted back toward youthful levels by NMN treatment
of aged mice.
We realized that significance cutoffs to identify dif-
ferentially expressed genes shared between the age-
effect and NMN-effect datasets may be too stringent,
and the analysis illustrated in Fig. 1d may miss discor-
dant patterns (youthful shifts) of gene expression with
important biological relevance for NMN-induced
neurovascular rejuvenation. Thus, we also used an ap-
proach to detect discordant transcriptional patterns
(youthful shifts) by comparing the age-effect and
NMN-effect gene expression datasets using combina-
tion criteria that took into account the effect direction.
Genes were ranked by their effect size direction, and
ranked lists were compared to identify overlapping
genes across a continuous significance gradient. Our
analysis required that discordant genes with youthful
shifts (1) are “differentially expressed” based on both
p value and fold-change criteria either in aging or the
NMN treatment group, (2) satisfy a fold-change criteri-
on with a cutoff of ≥ 1.5 or < 0.67 in the group in which
expression did not satisfy the statistical significance
p < 0.05, and (3) satisfy the criterion that the effect
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directions of the age-effect and NMN-effect are oppo-
site. We found that these combination criteria found
more biologically meaningful sets of genes than
p values alone.
In Fig. 1e, the magnitude of age-related changes in
gene expression is plotted against the magnitude of
NMN-induced changes in gene expression. Red sym-
bols denote discordant DE genes, whose expression
levels shifted back toward the young phenotype by
NMN treatment with statistical significance. Genes
which are DE only in one group but otherwise satisfy
the other criteria are denoted by blue (DE in aging) and
GeroScience
green (DE in NMN-treated) symbols. Using this ap-
proach, we have identified 466 discordant genes with
youthful shifts, which changed in opposite directions
between the two datasets (Fig. 1f). These data suggest
that NAD+ depletion has a critical role in age-related
dysregulation of neurovascular gene expression.
Transcriptional footprint of neurovascular SIRT1
activation in NMN-treated aged mice
Previous studies suggested that restoration of NAD+
levels in aged cells by NMN treatment activates the
NAD+-dependent histone deacetylase enzyme SIRT1
(Gomes et al. 2013; Tarantini et al. 2019a). To provide
additional evidence that SIRT1 activation contributes to
the neurovascular protective effects of NMN, we exam-
ined the transcriptional footprint of neurovascular
SIRT1 activation in NMN-treated aged mice using three
approaches. First, we analyzed age-related and NMN-
induced changes in expression of SIRT1-regulated
genes identified by IPA. We found that aging is associ-
ated with changes in the expression of several known
SIRT1-regulated genes and that majority of these tran-
scriptional changes are reversed by NMN treatment
(Fig. 2a).
Ingenuity upstream regulator analysis
We have also performed IPA upstream regulator analy-
sis (Kramer et al. 2014) to identify upstream transcrip-
tional regulators that may contribute to the observed
transcriptomic changes in our dataset, which can help
to identify the mechanism of action of NMN in the aged
neurovascular unit. The upstream regulator analysis is
based on information in the Ingenuity Knowledge Base
(a curated relational database of the available biomedi-
cal literature) on the expected effects between transcrip-
tional regulators and their target genes. Using the IPA
upstream regulator analysis, it was examined how many
known targets of each transcriptional regulator were
differentially expressed in our samples, and the direction
of these gene expression changes were compared with
what is expected from the literature. On the basis of the
observed direction of change, a prediction of the activa-
tion state of the predicted transcriptional regulators (“ac-
tivated” or “inhibited”) were made (not shown). For
each potential transcriptional regulator, two statistical
measures, an overlap p value and an activation z-score,
were computed. The overlap p value calls likely up-
stream regulators based on significant overlap between
the differentially expressed genes and known targets
regulated by that particular transcriptional regulator.
The activation z-score is used to infer the activation state
of the predicted transcriptional regulators (“activated” or
“inhibited”) based on comparison with a model that
assigns random regulation directions. The results of
the IPA upstream regulator analysis are visualized in
Fig. 2b. We also determined the link between the pre-
dicted upstream regulators activated by NMN and
SIRT1 using IPA. As indicated in Fig. 2b, we found that
~ 38% of the predicted upstream regulators activated by
Fig. 1 NMN treatment reverses age-related changes in
neurovascular mRNA expression profile. a Heatmap displaying
normalized mRNA expression values for each sample as com-
pared with that in cells of the neurovascular unit (endothelial cells,
astrocytes, and pericytes) from the reference datasets by Zhang
et al. (2014). Note that neurovascular genes are enriched in the
samples. b The heat map is a graphic representation of normalized
expression values of differentially expressed genes in
neurovascular samples derived from young (3 months old), aged
(24 months old), and NMN-treated aged mice. Hierarchical clus-
tering analysis revealed the similarities on neurovascular mRNA
expression profiles in young and NMN-treated aged mice. c Prin-
cipal component analysis (PCA) plot of neurovascular mRNA
expression profiles in young, aged control, and NMN-treated aged
mice. The profiles from aged mice (red) cluster separately from
clusters representing young mice (blue) and NMN-treated aged
mice (green). PC1, PC2, and PC3 are principal components 1, 2,
and 3, respectively. d Volcano plot depicting differentially
expressed genes comparing neurovascular samples derived from
young and aged mice. Stratified p values are plotted against
expression fold-changes for results obtained in aged samples nor-
malized to young samples. Colored points refer to genes whose
expression is significantly altered by NMN treatment. e NMN-
induced changes in gene expression plotted against age-related
changes in the neurovascular transcriptome. Red symbols indicate
discordant differentially expressed genes with youthful shifts,
whose expression significantly changes with age and is restored
by NMN treatment toward youthful levels. Blue and green sym-
bols denote discordant genes with youthful shifts, whose expres-
sion changes in aging and is restored by NMN treatment toward
youthful levels, but only the aging (blue) or the NMN effect
(green) reaches the cutoff for statistical significance. f Venn dia-
grams sowing the numbers of differentially expressed mRNAs in
each group. The blue circle represents neurovascular genes, which
are significantly up or downregulated in aged mice as compared
with young mice. The green circle represents neurovascular genes,
which are significantly up or downregulated in aged mice by
NMN treatment. The red area represents discordant differentially
expressed genes. Gray areas represent discordant genes, whose
expression is changed by NMN treatment toward youthful levels,
but the effect does not reach the cutoff for statistical significance
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NMN are known to be regulated by SIRT1-dependent
pathways. In particular, the IPA upstream regulator
analysis predicts that NMN-induced SIRT1 activation
upregulates PGC-1α (PPARGC1A), FOXO3- and
FOXO4-mediated pathways, whereas it inhibits HIF-
1α-regulated pathways (Fig. 2b). We also attempted to
Fig. 2 NMN reverses age-related changes in neurovascular ex-
pression of SIRT1-regulated genes. a IPA results showing age-
related (left) and NMN-induced (right) changes in the expression
of SIRT1-regulated genes (classified as such by IPA). Green,
downregulation; red, upregulation. b Results of the IPA upstream
regulator analysis. Shown are predicted upstream transcriptional
regulators that may contribute to the observed NMN-induced
transcriptomic changes in our dataset. Known links between the
predicted upstream regulators activated by NMN and SIRT1 ac-
tivity are indicated. c Literature-based relationships with positive
mutual information among the predicted upstream regulators.
Node size correlates with the activation z-score from IPA (bigger
= higher z-score), edge width correlates with the mutual informa-
tion of the genes within the literature, green marks which are
predicted activators and red marks predicted repressors. d The
heat map is a graphic representation of normalized expression
values of differentially expressed SIRT1-dependent genes in
neurovascular samples derived from young (3 months old), aged
(24 months old), and NMN-treated aged mice. Hierarchical clus-
tering analysis revealed the similarities on neurovascular expres-
sion profiles of SIRT1-dependent genes in young and NMN-
treated aged mice. SIRT1-dependent genes were identified based
on their differential expression in the brain of SIRT1−/− mice
(Libert et al. 2011)
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predict NMN-activated, SIRT1-dependent regulatory
networks by identifying relationships between SIRT1
and the predicted upstream regulators utilizing the IRI-
DESCENT (Implicit Relationship IDEntification by in-
Silico Construction of an Entity-based Network from
Text) system (Wren and Garner 2004). IRIDESCENT
processes all available MEDLINE abstracts and uses a
statistical model to determine whether each upstream
regulator co-occurs with a term of interest more fre-
quently than would be expected by chance, and quan-
tifies this in terms of the mutual information measure.
The results of this analysis provide additional support to
the view that the predicted NMN-induced SIRT1 acti-
vation results in inhibition of HIF-1α29 and activation of
PGC-1α- and FOXO3-dependent pathways (Hubbard
et al. 2013). PGC-1α and FOXOs are known targets for
SIRT1-mediated deacetylation (Fig. 2c).
In addition, we also intersected the list of differen-
tially expressed genes in our dataset with the list of
genes differentially expressed in the brains of SIRT1−/−
mice (NCBI Gene Expression Omnibus: GSE28790)
(Libert et al. 2011). The heat map showing the expres-
sion pattern of these SIRT1-sensitive genes is shown in
Fig. 2d. Hierarchical clustering of the data showed a
clear separation between the young and aged groups.
Aged control mice and aged NMN-treated mice were
also clearly separated. In contrast, expression of SIRT1-
sensitive genes in young mice and NMN-treated aged
mice were similar, and these groups did not separate
well in the hierarchical clustering, consistent with the
idea that aging is associated with dysregulation of
SIRT1-sensitive genes, which is rescued by NMN
treatment.
NMN-induced neurovascular transcriptomic changes
in aged mice predict mitochondrial rejuvenation
We performed GO enrichment analysis to explore po-
tential biological functions of the NMN-regulated dis-
cordant differentially expressed genes with youthful
shifts. GO enrichment analysis of discordant differen-
tially expressed genes with youthful shifts identified
functions in mitochondrial regulation and oxidative
stress, apoptosis, inflammation, endothelial activation,
and transcriptional regulation (Fig. 3).
Our recent studies, demonstrate that aging is associ-
ated with mitochondrial dysfunction and oxidative
stress in cerebromicrovascular endothelial cells, which
play a critical role in dysregulation of cerebral blood
flow and impaired neurovascular coupling responses in
aged mice (Tarantini et al. 2018, 2019a). To find out
whether mitochondria-related gene expression is altered
in the aging NVU, we analyzed expression of both
nuclear-encoded and mtDNA-encoded mitochondria-
related genes. We have used existing databases to com-
pile a list of genes with mitochondrial targeting se-
quences and known functions related to regulation of
mitochondrial processes. We used Gene Set Enrichment
Analysis (GSEA) for interpreting expression of
mitochondria-related genes (Subramanian et al. 2005).
GSEA of mtDNA-encoded genes encoding components
of the mitochondrial electron transport chain (ETC) was
performed using a pre-ranked gene list based on the
magnitude of the fold-change (largest upregulation to
most downregulated; Fig. 4a, b). Figure 4a, b depict a
running-sum statistic (enrichment score) based on Fig.
4, increasing when a gene is a member of the mtDNA-
encoded ETC gene set and decreasing when it is not.
Note that in aged mice, GSEA scores increased predom-
inantly on the right indicating downregulation of
mtDNA-encoded ETC genes by aging. In contrast, in
NMN-treated aged mice GSEA scores increased pre-
dominantly on the left indicating upregulation of
mtDNA-encoded ETC genes byNMN treatment in aged
mice. The heat maps showing the expression pattern of
nuclear-encoded and mtDNA-encoded mitochondria-
related genes are shown in Fig. 4 c and d, respectively.
Hierarchical clustering of the data showed a clear sepa-
ration between the young and aged groups. Aged con-
trol mice and aged NMN-treated mice were also sepa-
rated. In contrast, expression of mitochondria-related
genes in young mice and NMN-treated aged mice were
similar, and these groups did not separate well in the
hierarchical clustering, consistent with the idea that age-
related dysregulation of mitochondria-related genes in
the NVU is reversed, at least in part, by NMN treatment.
Fig. 3 Most significantly enriched Gene Ontology (GO) terms for
discordant genes. Note that NMN treatment is associated with
transcriptional changes indicating multifaceted anti-inflammatory,
anti-apoptotic, mitochondrial protective, and anti-oxidative effects
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NMN-induced neurovascular transcriptomic changes
in aged mice predict anti-apoptotic effects
Previous studies suggest that endothelial cell apoptosis
plays a critical role in age-related structural remodeling
of cerebromicrovascular network by contributing to mi-
crovascular rarefaction (Ungvari et al. 2018a, b). To
determine how NMN treatment alters apoptosis-related
gene expression in the aging NVU, we analyzed
expression of genes known to be involved in regulation
of programmed cell death. Apoptosis-related genes were
identified based on GO classification. GSEA analysis
suggested that aging is associated with upregulation of
pro-apoptotic genes, which tends to be reversed by
NMN treatment (Fig. 5a, b). KEGG pathway map
depicting age- and NMN treatment-related changes in
the expression of genes in the apoptosis pathways is
shown in Fig. 5c.
Fig. 4 NMN treatment reverses age-related changes in
neurovascular expression of mitochondria-related genes. Gene
Set Enrichment Analysis (GSEA) to test for enrichment of the
set of mtDNA-endcoded subunits of the electron transport chain
(ETC) by comparing NVU samples derived from aged (24months
old) mice with NVU samples derived from young (3 months old)
mice (a) and NMN-treated aged NVU samples with untreated
aged NVU samples (b). Aging-induced gene expression changes
were ranked from most upregulated (left, red) to most downregu-
lated (right, green). Dots represent identified mtDNA-encoded
ETC genes. Panels a, b depict a running-sum statistic (enrichment
score) based on panel c, increasing when a gene is a member of the
mtDNA-encoded ETC gene set and decreasing when it is not.
Note that in aged mice, GSEA scores increased predominantly on
the right indicating downregulation of mtDNA encoded ETC
genes by aging. In contrast, in NMN-treated aged mice GSEA
scores increased predominantly on the left indicating upregulation
of mtDNA-encoded ETC genes by NMN treatment in aged mice.
The heat maps are graphic representations of normalized expres-
sion values of differentially expressed mtDNA-encoded ETC
genes (c) and nuclear-encoded mitochondria-related genes (d).
Hierarchical clustering analysis revealed the similarities on
neurovascular expression profiles of mitochondria-related genes
in young andNMN-treated agedmice. Mitochondria-related genes
were identified on the basis of GO classifications (GO:0005739).
Note that one young sample was a statistical outlier and was
therefore excluded from the mtDNA-encoded gene expression
analysis
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NMN-induced neurovascular transcriptomic changes
predict anti-inflammatory effects, including inhibition
of endothelial activation in aged mice
Chronic low-grade inflammation, characterized by endo-
thelial activation, is a hallmark of vascular aging
(Ungvari et al. 2018b, 2007a; Csiszar et al. 2007, 2004,
2003). To elucidate the putative anti-inflammatory effects
of NMN treatment, we assessed its effect on the expres-
sion of endothelial activation–related genes. Endothelial
activation–related genes were identified based on
published microarray data (GEO database; GSE45880),
showing mRNA expression changes after activation of
cultured cerebromicrovascular endothelial cells
(CMVECs) by 10 ng/mL TNFα and IFNγ (Lopez-
Ramirez et al. 2013). GSEA analysis showed that aging
is associated with upregulation of endothelial activation–
related genes in the NVU (Fig. 6a). We found that NMN
treatment exerts significant anti-inflammatory effects,
downregulating endothelial activation–related genes in
the NVU (Fig. 6b). The heat map shown in Fig. 6c is a
graphic representation of normalized expression values
Fig. 5 NMN treatment reverses age-related changes in
neurovascular expression of apoptosis-related genes. Gene Set
Enrichment Analysis (GSEA) to test for enrichment of the set of
pro-apoptotic genes by comparing NVU samples derived from
aged (24months old)mice with NVU samples derived from young
(3 months old) mice (left, a) and NMN-treated aged NVU samples
with untreated aged NVU samples (right, b). Aging-induced gene
expression changes were ranked from most upregulated (left, red)
to most downregulated (right, green). Dots represent identified
pro-apoptotic genes. Panels a and b depict a running-sum statistic
(enrichment score) based on panel b, increasing when a gene is a
member of the apoptosis-related gene set and decreasing when it is
not. Note that in agedmice, GSEA scores increased predominantly
on the left indicating upregulation of pro-apoptotic genes by aging.
In contrast, in NMN-treated aged mice, GSEA scores increased
predominantly on the right indicating downregulation of pro-
apoptotic genes by NMN treatment in aged mice. b Kyoto Ency-
clopedia of Genes and Genomes (KEGG) pathway map depicting
age- and NMN treatment-related changes in the expression of
genes in the apoptosis pathways. Each rectangle on the map
represents a gene product in the apoptosis pathway. The rectangles
are set to color by age-related (left side) and NMN treatment-
induced (right side) changes in gene expression (fold-change).
Red color indicates upregulation, green color indicates downreg-
ulation. Genes involved in positive regulation of apoptosis were
identified based on GO classification
GeroScience
of differentially expressed endothelial activation–related
genes in NVU samples derived from young, aged, and
NMN-treated aged mice. We also found that 17 genes,
which are important for blood-brain barrier integrity
(Nyul-Toth et al. 2016) were significantly affected by
NMN treatment (data not shown) (Fig. 7).
Discussion
Our study demonstrates that protective effects of NMN
treatment on cerebromicrovascular endothelial function
and neurovascular coupling responses are associated
with anti-aging changes in the mRNA expression profile
in the NVU in a mouse model of aging that recapitulates
vascular alterations and deficits present in elderly
humans at risk for vascular cognitive impairment.
To our knowledge, this is the first study to demon-
strate that NMN treatment in aged mice reverses, at
least in part, age-related, pro-inflammatory, pro-oxi-
dative, pro-apoptotic, and endothelial dysfunction-
promoting transcriptional alterations in the cerebral
microcirculation. The results of the present study ex-
tend the findings of earlier investigations showing that
treatment with NMN confers potent anti-aging
neurovascular effects in aged mice, rescuing
Fig. 6 NMN treatment reverses age-related changes in
neurovascular expression of endothelial activation-related genes.
Gene Set Enrichment Analysis (GSEA) to test for enrichment of
the set of endothelial activation-related genes by comparing NVU
samples derived from aged (24 months old) mice with NVU
samples derived from young (3 months old) mice (a) and NMN-
treated aged NVU samples with untreated aged NVU samples (b).
Aging-induced gene expression changes were ranked from most
upregulated (left, red) to most downregulated (right, green). Dots
represent identified endothelial activation–related genes. Panels a,
b depict a running-sum statistic (enrichment score) based on the
upregulated endothelia activation–related genes in panel c, in-
creasing when a gene is a member of the endothelial activation–
related gene set and decreasing when it is not. Note that in aged
mice, GSEA scores increased predominantly on the left indicating
upregulation of endothelial activation–related genes by aging. In
contrast, in NMN-treated aged mice, GSEA scores increased
predominantly on the right indicating downregulation of endothe-
lial activation–related genes by NMN treatment in aged mice. c
The heat map is a graphic representation of normalized expression
values of differentially expressed endothelial activation–related
genes in neurovascular samples derived from young, aged, and
NMN-treated aged mice. Hierarchical clustering analysis revealed
the similarities on neurovascular expression profiles of endothelial
activation–related genes in young and NMN-treated aged mice.
Endothelial activation–related genes were identified based on
published microarray data (GEO database; GSE45880), showing
a distinct transcriptional signature of up and downregulated genes
after activation of cultured cerebromicrovascular endothelial cells
with 10 ng/mL TNFα and IFNγ (Lopez-Ramirez et al. 2013).
Included in the figure are genes whose expression in aging chang-
es similarly to the expressional changes observed in vitro upon
cytokine stimulation. Discordant genes are shown in red font
(bold, DE both in aging and NMN treated groups)
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cerebromicrovascular endothelial dysfunction and
neurovascular coupling responses, increasing cerebral
blood flow, and improving cognitive performance
(Yoshino et al. 2018). Demonstration of NMN-
induced phenotypic and functional changes in the
NVU is particularly important as neurovascular alter-
ations (including impaired neurovascular coupling,
blood-brain barrier disruption, and pro-inflammatory
changes) associated with aging have been causally
linked to the development of both neurodegenerative
diseases and the entire spectrum of brain pathologies
that contribute to vascular cognitive impairment
(Iadecola 2017; Toth et al. 2017; Sweeney et al.
2019b). Endothelial protective effects of NMN have
also been demonstrated in the peripheral circulation of
aged mice (Das et al. 2018; Yoshino et al. 2018; de
Picciotto et al. 2016), suggesting that the effects of
NMN on endothelial cells in the NVU likely play a
key role in NMN-induced neurovascular rejuvenation.
Administration of NMN or other NAD+ precursors
(e.g., nicotinamide riboside) to aged mice was report-
ed to increase NAD+ levels in homogenates of com-
plex tissues derived from multiple organs (Yoshino
et al. 2018; Mills et al. 2016; Zhang et al. 2016),
including the aorta (Tarantini et al. 2019a). In vitro
treatment with NMNwas also demonstrated to restore
NAD+ levels in aged cerebromicrovascular endothe-
lial cells (Tarantini et al. 2019a). Future studies should
determine how in vivo NMN treatment affects NAD+
levels in each cell type constituting the NVU and
elucidate the cell type–specific functional and
transcriptomic effects of NMN treatment in aging.
Fig. 7 Proposed scheme for the mechanisms by which restoration
of NAD+ levels in the aged neurovascular unit by NMN supple-
mentation promotes neurovascular rejuvenation. Themodel, based
on our present and previous findings and earlier data from the
literature (Das et al. 2018; Tarantini et al. 2019a; Csiszar et al.
2019), predicts that increased NAD+ activates sirtuin-mediated
pathways, which leads to anti-aging transcriptomic changes, re-
stores cellular energetics, and attenuates mitochondrial ROS
production, rescuing a youthful neurovascular phenotype. These
effects are predicted to act to improve endothelial function, in-
crease neurovascular coupling responses, capillary density and
cerebral blood flow (CBF), maintain blood-brain barrier (BBB)
integrity, and inhibit neuroinflammation, protecting cognitive
health (bold font, experimentally validated effects; regular fonts,
predicted effects)
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Our study demonstrates that NMN treatment, which
augments the vascular NAD+ metabolome (Tarantini
et al. 2019a), induces a neurovascular gene expression
signature suggestive of SIRT1 activation. Our results
expand the findings of previous studies showing that
increases in NAD+ levels induced by NMN treatment
also activate SIRT1 in skeletal muscle (Gomes et al.
2013). As our recent studies demonstrate that shRNA
knockdown of SIRT1 prevents the beneficial effects of
NMN on aged cerebromicrovascular endothelial cells
in vitro (Tarantini et al. 2019a), we posit that NMN-
induced SIRT1 activation plays a critical role also in
neurovascular rejuvenation in vivo. Sirtuins are
known to mediate beneficial anti-aging (Cohen et al.
2004; Moroz et al. 2014; Wood et al. 2004) and
vasoprotective effects (Csiszar et al. 2009a, 2013;
2014a) of caloric restriction as well. Our bioinformat-
ics analysis also revealed a role for Hif1α signaling,
confirming earlier findings (Gomes et al. 2013). Fur-
ther, our recent study demonstrate that NMN treatment
reverses age-related changes in miRNA expression in
the agedmouse aorta (Kiss et al. 2019b). In that regard,
it is significant that dysregulation of miRNA expres-
sion has been shown to significantly contribute to age-
related phenotypic and functional changes in the
cerebromicrovascular endothelial cells as well
(Ungvari et al. 2013). These findings raise the possi-
bility that complex changes in transcriptional and/or
post-transcriptional control of expression of genes that
encode critical factors determining neurovascular
health contribute to the beneficial effects of treatment
with NAD+ boosters. GO enrichment analysis of dis-
cordant differentially expressed neurovascular genes
identified functions in mitochondrial regulation, apo-
ptosis, inflammation, and endothelial activation.
Mitochondrial dysfunction and increased mito-
chondrial oxidative stress have a critical role in the
genesis of aging-induced cerebromicrovascular endo-
thelial impairment and neurovascular dysfunction
(Tarantini et al. 2018, 2019a). In support of this
concept, attenuation of mitochondrial oxidative stress
and restoration of mitochondrial energy metabolism
in the cerebromicrovascular endothelial cells by
treatment with the mitochondria-targeted antioxi-
dants were shown to rescue neurovascular function
in aged mice (Tarantini et al. 2018). Here, we report
that NMN treatment rescues aging-induced changes
in mitochondria-related gene expression in the NVU.
Importantly, these NMN-induced changes in the
mitochondria-related transcriptome are associated
with attenuated mitochondrial oxidative stress and
restoration of mitochondrial energy metabolism in
aging cerebromicrovascular endothelial cells
(Tarantini et al. 2019a; Kiss et al. 2019a). On the
basis of previous findings (Gomes et al. 2013), we
posit that rescue of vascular mitochondrial function
by restoring the expression of ETC subunits contrib-
utes to the neurovascular protective effects of NMN.
Treatment with NMN was also shown to rescue ex-
pression of mitochondrial-encoded ETC subunits in
cerebral arter ies of aged mice and in aged
cerebromicrovascular endothelial cells (Gomes et al.
2013). It is believed that rescue of electron flow
through the electron transport chain, due to the re-
stored expression of complex I and complex III
(Kwong and Sohal 2000), likely attenuates electron
leak, limiting mtROS production. Treatment with
NAD+ boosters was also demonstrated to upregulate
mitochondrial gene expression in the mouse skeletal
muscle (Canto et al. 2012). Our recent studies pro-
vide evidence that NMN treatment exerts its mito-
chondrial protective effects in cerebromicrovascular
endothelial cells in a SIRT1-dependent manner
(Gomes et al. 2013). Our observations accord with
findings from earlier studies showing that many of
the health benefits conferred by SIRT1 activation are
linked to improved mitochondrial function (Baur
et al. 2006). In addition to sirtuin-mediated
transcriptomic effects, a mitochondrial ATP produc-
tion requires NAD+ as an essential cofactor, rescuing
normal cellular NAD/NADH ratio per se may also
promote efficient mitochondrial function in cells of
the NVU.
Analysis of the transcriptomic signature of NMN
treatment predicts potent anti-apoptotic effects in the
NVU. This is significant, as endothelial cell apoptosis
plays a critical role in age-related cerebromicrovascular
rarefaction (Ungvari et al. 2018a, b). Thus, future stud-
ies should determine how NMN treatment affects the
number of apoptotic endothelial cells in the NVU as
well as capillary density in the aged brain. Recent stud-
ies show that NMN also protects the integrity of the
blood-brain barrier in a mouse model of brain ischemia
(Wei et al. 2017). On the basis of our findings that NMN
upregulates factors controlling barrier integrity, it will be
also of great interest to determine whether NMN treat-
ment can also protect against age-related disruption of
the blood-brain barrier.
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Our studies demonstrate that NMN treatment in
aged mice reverses, at least in part, age-related, pro-
inflammatory alterations in mRNA expression pro-
file in the NVU. Our findings expand the results of
recent studies demonstrating that treatment of aged
mice with NMN promotes anti-inflammatory pheno-
typic changes in the peripheral vasculature as well
(Kiss et al. 2019b). Previous studies attributed age-
related endothelial activation and chronic sterile mi-
crovascular inflammation to oxidative stress-
mediated activation of NF-κB and upregulation of
pro-inflammatory cytokines in the vascular wall
(Csiszar et al. 2003, 2008b, 2014a; Ungvari et al.
2007a). SIRT1 activation is known to attenuate cel-
lular and mitochondrial oxidative stress, inhibit
NF-κB, and attenuate microvascular inflammation
(Toth et al. 2015; Csiszar et al. 2008a, 2012; Baur
et al. 2012; Ungvari et al. 2009; Zhang et al. 2009;
Mattison et al. 2014). Thus, it is likely that SIRT1
activation and the previously documented anti-
oxidative neurovascular effects contribute signifi-
cantly to the observed anti-inflammatory effects as-
sociated with NMN treatment.
Additional studies are warranted to determine the
efficacy of combination treatments with NAD+
boosters (Mitchell et al. 2018; Yoshino et al. 2018;
Liu et al. 2018) and compounds that directly acti-
vate SIRT1 and/or inhibit NAD+ overutilization for
neurovascular protection. Similar to NAD+ boosters,
SIRT1-activating compounds (STACs; including
resveratrol and SRT1720) were demonstrated to ex-
ert important vasoprotective effects in models of
aging and accelerated vascular aging (Csiszar et al.
2008a; Ungvari et al. 2007a, b, 2011; Pearson et al.
2008; Zarzuelo et al. 2013; Chen et al. 2015; Gano
et al. 2014; Minor et al. 2011). These SIRT1-
mediated effects include increased mitochondrial
biogenesis (Csiszar et al. 2009b), attenuation of
mitochondrial oxidative stress (Ungvari et al. 2009;
Csiszar et al. 2012), activation of anti-oxidative
defense mechanisms (Csiszar et al. 2014b), and
inhibition of apoptosis (Pearson et al. 2008). Treat-
ment with the STAC resveratrol was shown to im-
prove cerebromicrovascular endothelial function and
rescue neurovascular coupling responses in aged
mice (Toth et al. 2014; Wiedenhoeft et al. 2019).
Resveratrol was also shown to increase capillary
density (Oomen et al. 2009) and prevent microvas-
cular fragility (Toth et al. 2015) in the aged mouse
brain and to exert similar vasoprotective effects in
non-human primate models as well (Mattison et al.
2014; Bernier et al. 2016). The molecular mecha-
nisms contributing to age-related decline in NAD+
in cells of the NVU are likely multifaceted. In
addition to downregulation of NAMPT (nicotin-
amide phosphoribosyltransferase/NMN synthase;
which catalyzes the rate limiting step in the biosyn-
thesis of NAD+) (Tarantini et al. 2019a), the in-
c reased ut i l i za t ion of NAD+ by act iva ted
poly(ADP-ribose) polymerase 1 (PARP-1) (Csiszar
et al. 2019; Pacher et al. 2002) also likely plays an
important role in age-related decline in NAD+ in the
NVU. Accordingly, treatment with PJ-34, a potent
PARP inhibitor, restores neurovascular coupling re-
sponses in aged mice, similar to the neurovascular
protective effects of NMN treatment (Tarantini et al.
2019b). Thus, future studies should determine
whether combination of NAD+ boosters with
STACs, mitochondria-targeted agents, and/or
PARP-1 inhibitors confers greater neurovascular
and cognitive health benefits as compared with
NAD+ booster treatment alone.
Conclusions
In conclusion, rescue of cerebromicrovascular endo-
thelial function and neurovascular coupling re-
sponses in NMN-treated aged mice are accompanied
by marked anti-aging changes in the neurovascular
transcriptome. We hope that our findings will facili-
tate future endeavors to uncover the mechanistic role
of neurovascular NAD+ depletion in brain aging and
the pathogenesis of VCI. The recently appreciated
complex role of NVU dysfunction (ranging from
impaired neurovascular coupling to blood-brain bar-
rier disruption) in neurodegenerative diseases and
VCI supports the concept that pharmacological treat-
ments, which maintain neurovascular health, promote
brain health (Kisler et al. 2017; Zlokovic 2010, 2011;
Csipo et al. 2019a, b; de Montgolfier et al. 2019;
Farias Quipildor et al. 2019; Fulop et al. 2019;
Sorond et al. 2019; Sagare et al. 2013). Potentially,
NAD+ booster treatments (e.g., in combination with
STACs) could be harnessed for development of new
pharmacological approaches for neurovascular pro-
tection for the prevention and treatment of VCI and
neurodegenerative diseases in older adults.
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